Study suggests Pfizer Covid-19 vaccine may only partially protect against Omicron

The preliminary data does not indicate that the vaccine is less able to prevent severe illness or death.

The Omicron variant of the coronavirus can partially evade the protection from two doses of Pfizer and partner BioNTech's Covid-19 vaccine, the research head of a laboratory at the Africa Health Research Institute in South Africa said on Tuesday.